Division of Rheumatology, Hospital for Special Surgery, New York City, New York, USA
Medicine, Weill Cornell Medicine, New York City, New York, USA.
Lupus Sci Med. 2023 Jul;10(2). doi: 10.1136/lupus-2023-000905.
Frailty is a risk factor for adverse health in adults with SLE, including those <65 years. Emergency department (ED) utilisation is high in adults with SLE, but to our knowledge, whether frailty is associated with ED use is unknown. In a large administrative claims dataset, we assessed risk of ED utilisation among frail adults with SLE ≤65 years of age relative to non-frail adults ≤65 years of age with SLE.
Using the MarketScan Medicaid subset from 2011 to 2015, we identified beneficiaries 18-65 years with SLE (≥3 SLE International Classification of Diseases, Ninth Revision codes ≥30 days apart). Comparators without a systemic rheumatic disease (SRD) were matched 4:1 on age and gender. Frailty status in 2011 was determined using two claims-based frailty indices (CFIs). We compared risk of recurrent ED utilisation among frail and non-frail beneficiaries with SLE using an extension of the Cox proportional hazard model for recurrent events data.
Of 2262 beneficiaries with SLE and 9048 non-SRD comparators, 28.8% and 11.6% were frail, respectively, according to both CFIs. Compared with non-frail beneficiaries with SLE, frail beneficiaries with SLE had significantly higher hazard of recurrent ED use (HR 1.75, 95% CI 1.48 to 2.08).
Frailty increased hazard of recurrent ED visits in frail adults ≤65 years of age with SLE relative to comparable non-frail adults with SLE. Frailty is a potential target for efforts to improve quality of care in SLE.
衰弱是 SLE 成人(包括 <65 岁)不良健康的一个风险因素。SLE 成人的急诊科(ED)利用率较高,但据我们所知,衰弱是否与 ED 使用相关尚不清楚。在一项大型行政索赔数据集中,我们评估了≤65 岁衰弱的 SLE 成人相对于≤65 岁非衰弱 SLE 成人的 ED 使用率风险。
使用 2011 年至 2015 年 MarketScan Medicaid 子集,我们确定了年龄在 18-65 岁之间且患有 SLE(≥3 个 SLE 国际疾病分类,第九版代码,间隔 ≥30 天)的受益人群。无系统性风湿性疾病(SRD)的对照者按年龄和性别 4:1 匹配。2011 年衰弱状态采用两种基于索赔的衰弱指数(CFIs)确定。我们使用复发性事件数据的 Cox 比例风险模型的扩展来比较患有 SLE 的衰弱和非衰弱受益人群的 ED 再利用风险。
在 2262 名患有 SLE 的受益人和 9048 名非-SRD 对照者中,根据两个 CFIs,分别有 28.8%和 11.6%的人衰弱。与非衰弱的 SLE 受益人群相比,衰弱的 SLE 受益人群的 ED 再利用复发性风险显著更高(HR 1.75,95%CI 1.48 至 2.08)。
衰弱增加了≤65 岁患有 SLE 的衰弱成年人群相对于可比的非衰弱 SLE 成年人群 ED 再就诊的风险。衰弱是提高 SLE 护理质量的潜在目标。